about
Prediction of psilocybin response in healthy volunteersGPCR oligomers in pharmacology and signalingPharmacology of hallucinations: several mechanisms for one single symptom?Metabotropic glutamate mGlu2 receptor is necessary for the pharmacological and behavioral effects induced by hallucinogenic 5-HT2A receptor agonistsIdentification of three residues essential for 5-hydroxytryptamine 2A-metabotropic glutamate 2 (5-HT2A·mGlu2) receptor heteromerization and its psychoactive behavioral functionHead-twitch response in rodents induced by the hallucinogen 2,5-dimethoxy-4-iodoamphetamine: a comprehensive history, a re-evaluation of mechanisms, and its utility as a model.Heteromerization of G protein-coupled receptors: relevance to neurological disorders and neurotherapeutics.Preclinical models of antipsychotic drug action.Epigenetic Mechanisms of Serotonin Signaling.Structure-activity relationships of constrained phenylethylamine ligands for the serotonin 5-HT2 receptorsIn Vitro and In Vivo Characterization of the Alkaloid NuciferinePreclinical evaluation of the antipsychotic potential of the mGlu2-positive allosteric modulator JNJ-40411813.Animal models of serotonergic psychedelics.HDAC2 regulates atypical antipsychotic responses through the modulation of mGlu2 promoter activity.Mismatch negativity encoding of prediction errors predicts S-ketamine-induced cognitive impairments.Quantitative phosphoproteomics unravels biased phosphorylation of serotonin 2A receptor at Ser280 by hallucinogenic versus nonhallucinogenic agonists.Chemistry-based molecular signature underlying the atypia of clozapine.Serotonin 2A receptor agonist binding in the human brain with [¹¹C]Cimbi-36.Activity-dependent serotonergic excitation of callosal projection neurons in the mouse prefrontal cortex.5-HT radioligands for human brain imaging with PET and SPECTDecoding the signaling of a GPCR heteromeric complex reveals a unifying mechanism of action of antipsychotic drugs.Drug-induced psychosis: how to avoid star gazing in schizophrenia research by looking at more obvious sources of light.Maternal influenza viral infection causes schizophrenia-like alterations of 5-HT₂A and mGlu₂ receptors in the adult offspring.Resting-state functional connectivity of the nucleus accumbens in auditory and visual hallucinations in schizophrenia.PET tracers for serotonin receptors and their applicationsEffects of hallucinogenic agents mescaline and phencyclidine on zebrafish behavior and physiology.Htr2a Expression Responds Rapidly to Environmental Stimuli in an Egr3-Dependent Manner.Disruption of prefrontal cortex large scale neuronal activity by different classes of psychotomimetic drugsActivation of 5-HT2A receptors upregulates the function of the neuronal K-Cl cotransporter KCC2.Persistent effects of chronic clozapine on the cellular and behavioral responses to LSD in miceDysregulated 5-HT(2A) receptor binding in postmortem frontal cortex of schizophrenic subjectsEffect of Some Psychoactive Drugs Used as 'Legal Highs' on Brain NeurotransmittersRepressive epigenetic changes at the mGlu2 promoter in frontal cortex of 5-HT2A knockout mice.Prenatal stress induces schizophrenia-like alterations of serotonin 2A and metabotropic glutamate 2 receptors in the adult offspring: role of maternal immune systemGroup II metabotropic glutamate receptors and schizophrenia.Functional associations among G protein-coupled neurotransmitter receptors in the human brainA novel aminotetralin-type serotonin (5-HT) 2C receptor-specific agonist and 5-HT2A competitive antagonist/5-HT2B inverse agonist with preclinical efficacy for psychoses.Functional topography of midbrain and pontine serotonergic systems: implications for synaptic regulation of serotonergic circuits.Zebrafish models to study drug abuse-related phenotypes.Relationships among variables and their equilibrium values: caveats of time-less interpretation.
P2860
Q21134798-AB73E39F-D7CF-4DEF-940B-A5D37D6AB18FQ21198901-A10B4F37-27EB-4A61-8BB5-CF6915CBAE14Q21284720-9FCCBFB8-0B5A-4BB2-B69E-B53FD1481A48Q22251267-D85D47F3-78B0-46BA-A5CF-A0FD2A9201F9Q24594672-5514FA91-5E0E-419A-B09D-8306A5E833D2Q24595389-0BD3A542-DD68-436D-9620-C7B11362CFDBQ24630645-4CC94D3A-F7C2-424C-A9AD-0447BB2219FAQ26827502-19F71D42-2D4F-4300-AC01-EBE67DDEA139Q27027985-F2647B51-47FC-4464-965D-7172397E8B0DQ28534941-80745DCB-C345-4E9F-B1EB-6E20D495B75BQ28550683-B6010C21-490D-4D7D-B1B4-409AE62CE645Q30418647-474237A3-928F-4B13-A973-794ACBEDAAB5Q30444312-08DC406A-4623-4113-9389-CDE9012E7623Q30457800-DB631D12-CF9E-4FB2-94D5-677D1302FF12Q30457813-B4036DCD-7BAE-42A3-A3BC-DC3A265F3C54Q33583171-C55E23CB-F631-45FC-9A82-30199335C7A3Q33707728-1E427217-C692-4D69-B397-6C4490202637Q33851479-70748672-BBEE-48A7-AD47-FD49298F11F3Q34087741-91F03CBF-0426-4B38-8442-34737B4A5AACQ34192729-D657968B-E422-4E51-8C11-77342015A549Q34236107-549111DE-33D0-43BE-BCFD-136D129BE1ADQ34509725-EABAA7C0-26DC-4F4E-9976-6589981E4D57Q34566313-64E6CCEC-FD1D-49AD-84C2-84C50D529F38Q34701047-C9CE8FA6-6852-4F10-97E4-2A6397138862Q35090637-0ED658A2-2AB2-45EF-81A4-D011EDCA15D9Q35803439-93828CF6-57D8-418B-B245-7FC6D57AC542Q36047803-7DC5999C-ED07-4CE1-AD21-7ED7734DAE3AQ36493481-78046971-65AA-4CC6-9207-4915C5FFDDF1Q36512082-4C44B9AC-2259-49B7-9C5E-DF3BD4C6D476Q36555130-74AE62F6-5977-4B37-9D25-A9D0A1797A26Q36652159-3DD84CDD-D0F6-4C30-9AF6-623F30EEE123Q36674322-8FE5328F-C303-403C-8AB9-179BC1A93D0DQ36852536-F187E7C9-E084-4C68-AF46-94867349762FQ37013377-CF8F2851-ECD8-49B1-B644-C8A02C5D066DQ37473779-CA89EF07-BB26-4313-83D6-76AE93139A04Q37502302-CC92F3CC-0F28-4033-9338-B402412156E6Q37707718-05C3CC0D-4934-4B7E-9FC5-9C54B88B8725Q37810811-F862888B-BC8F-4F99-A34C-DAF5A9312A2BQ37880096-387293AC-2BBE-4DD0-B91E-34B758346C7FQ37908178-F169E8D1-EFE9-4B6D-937D-2DA4FEE65E7A
P2860
description
2009 nî lūn-bûn
@nan
2009 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի մարտին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Psychedelics and schizophrenia.
@ast
Psychedelics and schizophrenia.
@en
Psychedelics and schizophrenia.
@nl
type
label
Psychedelics and schizophrenia.
@ast
Psychedelics and schizophrenia.
@en
Psychedelics and schizophrenia.
@nl
prefLabel
Psychedelics and schizophrenia.
@ast
Psychedelics and schizophrenia.
@en
Psychedelics and schizophrenia.
@nl
P1476
Psychedelics and schizophrenia.
@en
P2093
Javier González-Maeso
Stuart C Sealfon
P304
P356
10.1016/J.TINS.2008.12.005
P577
2009-03-05T00:00:00Z